
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
The success of any drug discovery project relies upon the quality of the lead that initiates the lead optimization process. What defines a 'quality lead', where these 'quality leads' come from and how one discovers them has been the subject of intense debate within the pharmaceutical industry, relies upon defining those properties that historically have led to successful drug discovery. This volume addresses these questions and specifically discusses diabetes, obesity and tuberculosis. *Presents the latest research in the field of drug discovery *Publishes.
This volume investigates the critical factors defining and identifying 'quality leads' in drug discovery, a cornerstone for successful lead optimization. The pharmaceutical industry has long debated the origins and discovery methods for these crucial starting points in drug development. This book synthesizes current research, focusing specifically on the application of these principles to the therapeutic areas of diabetes, obesity, and tuberculosis, aiming to elucidate the properties that have historically driven successful drug discovery outcomes.
This book is presented as a compilation of current research in medicinal chemistry, focusing on the crucial initial stages of drug discovery. The content appears geared towards researchers and professionals within the pharmaceutical industry, offering insights into defining and sourcing 'quality leads' for optimization. The specific inclusion of therapeutic areas like diabetes, obesity, and tuberculosis suggests a practical application of theoretical concepts to significant global health challenges. The volume aims to consolidate recent findings and ongoing debates within the field.
Page Count:
233
Publication Date:
2007-01-01
ISBN-10:
0080471315
ISBN-13:
9780080471310
No comments yet. Be the first to share your thoughts!